Global RNAi for Therapeutic Market Report, Forecast to 2022

  • Summary
    RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
    The global RNAi for Therapeutic market will reach xxx Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    ???
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    siRNA
    miRNA
    shRNA
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Alnylam Pharmaceuticals
    Arrowhead
    Dicerna Pharmaceuticals
    Mirna Therapeutics
    Quark Pharmaceuticals
    RXi Pharmaceuticals
    miRagen Therapeutics
    Gradalis
    Sirnaomics
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Cancer
    Cardiovascular
    HBV
    Other
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

  • Table of Contents
    1 Market Overview
    1.1 Objectives of Research
    1.1.1 Definition
    1.1.2 Specifications
    1.2 Market Segment
    1.2.1 Upstream
    1.2.2 Downstream
    1.2 Market Segment
    1.2.1 by Type
    1.2.1.1 siRNA
    1.2.1.2 miRNA
    1.2.1.3 shRNA
    1.2.2 by Application
    1.2.2.1 Cancer
    1.2.2.2 Cardiovascular
    1.2.2.3 HBV
    1.2.2.4 Other
    1.2.3 by Regions
    2 Industry Chain
    2.1 Industry Chain Structure
    2.2 Upstream
    2.3 Market
    2.3.1 SWOT
    2.3.2 Dynamics
    3 Environmental Analysis
    3.1 Policy
    3.2 Economic
    3.3 Technology
    3.4 Market Entry
    4 Market Segmentation by Type
    4.1 Market Size
    4.1.1 siRNA Market, 2011-2016
    4.1.2 miRNA Market, 2011-2016
    4.1.3 shRNA Market, 2011-2016
    4.2 Market Forecast
    4.2.1 siRNA Market Forecast, 2017-2022
    4.2.2 miRNA Market Forecast, 2017-2022
    4.2.3 shRNA Market Forecast, 2017-2022
    5 Market Segmentation by Application
    5.1 Market Size
    5.1.1 Cancer Market, 2011-2016
    5.1.2 Cardiovascular Market, 2011-2016
    5.1.3 HBV Market, 2011-2016
    5.1.4 Other Market, 2011-2016
    5.2 Market Forecast
    5.2.1 Cancer Market Forecast, 2017-2022
    5.2.2 Cardiovascular Market Forecast, 2017-2022
    5.2.3 HBV Market Forecast, 2017-2022
    5.2.4 Other Market Forecast, 2017-2022
    6 Market Segmentation by Region
    6.1 Market Size
    6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2011-2016
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
    6.1.2 North America
    6.1.2.1 North America Market, 2011-2016
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
    6.1.3 Europe
    6.1.3.1 Europe Market, 2011-2016
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
    6.1.4 South America
    6.1.4.1 South America Market, 2011-2016
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
    6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2011-2016
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
    6.2 Market Forecast
    6.2.1 Asia-Pacific Market Forecast, 2017-2022
    6.2.2 North America Market Forecast, 2017-2022
    6.2.3 Europe Market Forecast, 2017-2022
    6.2.4 South America Market Forecast, 2017-2022
    6.2.5 Middle East & Africa Market Forecast, 2017-2022
    7 Market Competitive
    7.1 Global Market by Vendors
    7.2 Market Concentration
    7.3 Price & Factors
    7.4 Marketing Channel
    8 Major Vendors
    8.1 Alnylam Pharmaceuticals
    8.1.2 Profile
    8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.2 Arrowhead
    8.2.1 Profile
    8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.3 Dicerna Pharmaceuticals
    8.3.1 Profile
    8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.4 Mirna Therapeutics
    8.4.1 Profile
    8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.5 Quark Pharmaceuticals
    8.5.1 Profile
    8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.6 RXi Pharmaceuticals
    8.6.1 Profile
    8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.7 miRagen Therapeutics
    8.7.1 Profile
    8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.8 Gradalis
    8.8.1 Profile
    8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.9 Sirnaomics
    8.9.1 Profile
    8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    9 Conclusion

  • Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly

  • Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly